Le Lézard
Classified in: Health
Subjects: SVY, WOM

Global In Vitro Fertilization (IVF) Services Market is Expected to Reach $19.676 Million by 2023 - Allied Market Research


PORTLAND, Oregon and PUNE, India, January 19, 2018 /PRNewswire/ --

According to a new report by Allied Market Research, titled, " In Vitro Fertilization (IVF Services) Market by Cycle Type and End User - Global Opportunity Analysis and Industry Forecast, 2017 - 2023," the global revenues of InVitro fertilization services market is projected to reach $19.676 million by 2023. The fresh cycle (non-donor) segment accounted for approximately 65.8% revenue share in 2016 and is expected to maintain its dominance during the forecast period.

     (Logo: http://photos.prnewswire.com/prnh/20140911/647229 )

The causes of infertility include advanced maternal age, ovulation disorder, damaged or blocked fallopian tube, premature ovarian failure, uterine fibroids, endometriosis, impaired sperm production or function, unexplained infertility.

Do Enquiry for Sample Report@ https://www.alliedmarketresearch.com/request-sample/678

By end user fertility clinics accounted for major share of the global IVF services market in 2016, and is projected to maintain this trend throughout the forecast period. The rise can be attributed to rise in the number of fertility clinics as well as the availability of wide range of fertility treatments under one roof coupled with government reimbursements. Fertility clinics and specialty hospitals play crucial roles in providing IVF treatments to couples seeking assistance for infertility treatments, and together they occupy over three-fourths share of the overall market.

Based on geography Asia-Pacific captured the highest market share in 2016, and is expected to grow rapidly during the forecast period, owing to high success rates of IVF in this market, followed by rising trend of fertility tourism. Europe accounted for about one third of the overall market revenue in 2016 mainly attributed to large number of IVF procedures in the country and is expected to grow at a CAGR of 5.3%. Spain was the highest revenue generating country in European IVF services market followed by U.K. and France.

Do Enquiry before purchasing Report@ https://www.alliedmarketresearch.com/purchase-enquiry/678

The IVF market in developing economies such as APAC has numerous opportunities due to the wide availability of IVF clinics and government reimbursements. Countries such as India, China, and Australia have emerged as key fertility tourism destinations in the past few decades.

Key Findings of the In Vitro Fertilization (IVF) Services Market: 

Ask for discount before buying@ https://www.alliedmarketresearch.com/get-discount/678

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Dhananjay Potle
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
[email protected]

Web: https://www.alliedmarketresearch.com


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: